Antihypertensive treatment

Jason G. Umans, Edgardo J. Abalos, F. Gary Cunningham

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter reviews use of antihypertensive drugs in pregnancy to rapidly control severe hypertension, treat primary or secondary chronic hypertension, and control blood pressure in preeclampsia. Summarized are drugs’ pharmacology, safety, and systematic reviews of their efficacy. Blood pressure control does not appear to prevent superimposed preeclampsia, or lessen the incidence of placental abruption. By contrast, treatment prevents severe or accelerated hypertension, perhaps decreasing or delaying the need for hospitalization or urgent early delivery. Several agents effectively control hypertension with acceptable risks to mother and fetus, while ACE inhibitors and angiotensin receptor blockers are contraindicated, especially after early pregnancy. Desperately needed are adequately powered prospective clinical trials that distinguish between women with essential hypertension, transient hypertension, or preeclampsia, and stratify treatment by severity of hypertension and by gestational age. Such trials should include systematic assessment of maternal and uteroplacental hemodynamics, fetal well-being, and long-term postnatal functional and developmental outcomes.

Original languageEnglish (US)
Title of host publicationChesley's Hypertensive Disorders in Pregnancy, Fourth Edition
PublisherElsevier Science
Pages419-438
Number of pages20
ISBN (Electronic)9780124078666
DOIs
StatePublished - Jan 1 2014

Fingerprint

Antihypertensive Agents
Hypertension
Pre-Eclampsia
Therapeutics
Mothers
Blood Pressure
Abruptio Placentae
Pregnancy
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Gestational Age
Hospitalization
Fetus
Hemodynamics
Clinical Trials
Pharmacology
Safety
Incidence
Pharmaceutical Preparations

Keywords

  • Antihypertensive drugs
  • Preeclampsia
  • Pregnancy
  • Systematic reviews

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Umans, J. G., Abalos, E. J., & Gary Cunningham, F. (2014). Antihypertensive treatment. In Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition (pp. 419-438). Elsevier Science. https://doi.org/10.1016/B978-0-12-407866-6.00019-5

Antihypertensive treatment. / Umans, Jason G.; Abalos, Edgardo J.; Gary Cunningham, F.

Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition. Elsevier Science, 2014. p. 419-438.

Research output: Chapter in Book/Report/Conference proceedingChapter

Umans, JG, Abalos, EJ & Gary Cunningham, F 2014, Antihypertensive treatment. in Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition. Elsevier Science, pp. 419-438. https://doi.org/10.1016/B978-0-12-407866-6.00019-5
Umans JG, Abalos EJ, Gary Cunningham F. Antihypertensive treatment. In Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition. Elsevier Science. 2014. p. 419-438 https://doi.org/10.1016/B978-0-12-407866-6.00019-5
Umans, Jason G. ; Abalos, Edgardo J. ; Gary Cunningham, F. / Antihypertensive treatment. Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition. Elsevier Science, 2014. pp. 419-438
@inbook{f6dd66ed2f0c4f2d9fbcd45e0a4f48a8,
title = "Antihypertensive treatment",
abstract = "This chapter reviews use of antihypertensive drugs in pregnancy to rapidly control severe hypertension, treat primary or secondary chronic hypertension, and control blood pressure in preeclampsia. Summarized are drugs’ pharmacology, safety, and systematic reviews of their efficacy. Blood pressure control does not appear to prevent superimposed preeclampsia, or lessen the incidence of placental abruption. By contrast, treatment prevents severe or accelerated hypertension, perhaps decreasing or delaying the need for hospitalization or urgent early delivery. Several agents effectively control hypertension with acceptable risks to mother and fetus, while ACE inhibitors and angiotensin receptor blockers are contraindicated, especially after early pregnancy. Desperately needed are adequately powered prospective clinical trials that distinguish between women with essential hypertension, transient hypertension, or preeclampsia, and stratify treatment by severity of hypertension and by gestational age. Such trials should include systematic assessment of maternal and uteroplacental hemodynamics, fetal well-being, and long-term postnatal functional and developmental outcomes.",
keywords = "Antihypertensive drugs, Preeclampsia, Pregnancy, Systematic reviews",
author = "Umans, {Jason G.} and Abalos, {Edgardo J.} and {Gary Cunningham}, F.",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-407866-6.00019-5",
language = "English (US)",
pages = "419--438",
booktitle = "Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition",
publisher = "Elsevier Science",
address = "United Kingdom",

}

TY - CHAP

T1 - Antihypertensive treatment

AU - Umans, Jason G.

AU - Abalos, Edgardo J.

AU - Gary Cunningham, F.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - This chapter reviews use of antihypertensive drugs in pregnancy to rapidly control severe hypertension, treat primary or secondary chronic hypertension, and control blood pressure in preeclampsia. Summarized are drugs’ pharmacology, safety, and systematic reviews of their efficacy. Blood pressure control does not appear to prevent superimposed preeclampsia, or lessen the incidence of placental abruption. By contrast, treatment prevents severe or accelerated hypertension, perhaps decreasing or delaying the need for hospitalization or urgent early delivery. Several agents effectively control hypertension with acceptable risks to mother and fetus, while ACE inhibitors and angiotensin receptor blockers are contraindicated, especially after early pregnancy. Desperately needed are adequately powered prospective clinical trials that distinguish between women with essential hypertension, transient hypertension, or preeclampsia, and stratify treatment by severity of hypertension and by gestational age. Such trials should include systematic assessment of maternal and uteroplacental hemodynamics, fetal well-being, and long-term postnatal functional and developmental outcomes.

AB - This chapter reviews use of antihypertensive drugs in pregnancy to rapidly control severe hypertension, treat primary or secondary chronic hypertension, and control blood pressure in preeclampsia. Summarized are drugs’ pharmacology, safety, and systematic reviews of their efficacy. Blood pressure control does not appear to prevent superimposed preeclampsia, or lessen the incidence of placental abruption. By contrast, treatment prevents severe or accelerated hypertension, perhaps decreasing or delaying the need for hospitalization or urgent early delivery. Several agents effectively control hypertension with acceptable risks to mother and fetus, while ACE inhibitors and angiotensin receptor blockers are contraindicated, especially after early pregnancy. Desperately needed are adequately powered prospective clinical trials that distinguish between women with essential hypertension, transient hypertension, or preeclampsia, and stratify treatment by severity of hypertension and by gestational age. Such trials should include systematic assessment of maternal and uteroplacental hemodynamics, fetal well-being, and long-term postnatal functional and developmental outcomes.

KW - Antihypertensive drugs

KW - Preeclampsia

KW - Pregnancy

KW - Systematic reviews

UR - http://www.scopus.com/inward/record.url?scp=84987792958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987792958&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-407866-6.00019-5

DO - 10.1016/B978-0-12-407866-6.00019-5

M3 - Chapter

AN - SCOPUS:84987792958

SP - 419

EP - 438

BT - Chesley's Hypertensive Disorders in Pregnancy, Fourth Edition

PB - Elsevier Science

ER -